Champions Oncology (CSBR) Misses Q1 EPS by 3c

September 14, 2023 5:30 AM EDT

Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.7 million.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings